Clinical Trial Update: Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer [Phase 2]

View source ↗

Summary

The document updates a Phase 2 clinical trial evaluating aspirin plus exemestane as adjuvant therapy for breast cancer, sponsored by the Chinese Academy of Medi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aspirin (Aspirin)
• Exemestane (Exemestane)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Breast Neoplasms | Phase 2 | Status: UNKNOWN